RohitAggarwalMD
Rheumatology • Pittsburgh, PAAssistant Professor, Medicine, University of Pittsburgh School of Medicine
Dr. Aggarwal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 5th Ave
Suite 3B Falk Medical Building
Pittsburgh, PA 15213Phone+1 412-647-6700
Education & Training
Rush University Medical CenterFellowship, Rheumatology, 2007 - 2009
UPMC Medical EducationResidency, Internal Medicine, 2004 - 2007
Delhi University College of Medical SciencesClass of 2003
Certifications & Licensure
FL State Medical License 2023 - Present
ME State Medical License Current
PA State Medical License 2004 - 2026
IL State Medical License 2007 - 2011
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Fellow American College of Rheumatology
Clinical Trials
- Acthar in Treatment of Refractory Dermatomyositis and Polymyositis Start of enrollment: 2013 Sep 01
- Predictor of Clinical Response to Acthar in Myositis Start of enrollment: 2017 Nov 06
Publications & Presentations
PubMed
- 1 citationsClinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project.Sara Faghihi-Kashani, Akira Yoshida, Francisca Bozan, Giovanni Zanframundo, Davide Rozza
Arthritis & Rheumatology. 2025-04-01 - The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project.Giovanni Zanframundo, Eduardo Dourado, Iazsmin Bauer-Ventura, Sara Faghihi-Kashani, Akira Yoshida
Annals of the Rheumatic Diseases. 2025-03-18 - Role of CD19 Chimeric Antigen Receptor T Cell Therapy in Idiopathic Inflammatory Myopathies.Anushka Aggarwal, Maha Almackenzie, Rohit Aggarwal
The Journal of Rheumatology. 2025-03-15
Journal Articles
- Author Correction: Treatment in MyositisChester V Oddis, Rohit Aggarwal, Nature
Lectures
- Autoantibodies Predict Treatment Response to Rituximab in Myositis76th Annual Scienific Meeting, Washington, DC, USA
- Autoantibodies Predict Treatment Response to Rituximab in MyositisAmerican College of Rheumatology, 76th Annual Scienific Meeting, Washington, DC, USA
Other
- Dupuytren's contractureAggarwal R, Anderson BC
http://www.uptodate.com/contents/dupuytrens-contracture
UpToDate, Wolters Kluwer Health - 2012-12-05 - de Quervain's tenosynovitisAggarwal R, Anderson BC
http://www.uptodate.com/contents/de-quervains-tenosynovitis
UpToDate, Wolters Kluwer Health - 2012-07-03 - Sarcoid arthropathyAggarwal R, Sequeira W
http://www.uptodate.com/contents/sarcoid-arthropathy
UpToDate, Wolters Kluwer Health - 2012-03-28 - Join now to see all
Press Mentions
CT Results in Myositis Inform Cancer Screening StrategiesMarch 24th, 2023- FDA Approves IV Immunoglobulin to Treat Adults with DermatomyositisAugust 17th, 2021
- FDA Approves Octapharma’s Octagam® 10% for Adult DermatomyositisJuly 20th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
